Ekei Labs

It uses genome-wide DNA methylation sequencing and AI-supported data analysis to help researchers understand what cells are doing, not only what their DNA enables them to do. The company describes epigenetic marks as measurable signals of cell state, disease, and treatment response.

Its services support target discovery and prioritization, biomarker discovery and validation, assessment of cells and products, manufacturing quality control, and statistical or machine-learning analysis tailored to research objectives. Clients can submit samples including blood, bulk cells, and oral swabs; the platform is also described as compatible with tissue and saliva and able to work with DNA inputs from 20 nanograms. Ekei labs says its enzymatic method preserves sample integrity while separating signal from noise, and that its sequencing covers more than 75% of the genome. The brand also offers a cell-testing kit intended to assess glycan-related inflammation and estimate biological age.